Research Article
Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Bronchogenic Carcinoma to the Liver: A Multi-Institutional Registry
Table 1
Clinical characteristics in 13 lung metastatic patients treated with LC beads.
| Characteristics | |
| Age (years) (median, range) | 68 (43–72) | Gender | | Male | 7 (54%) | Female | 6 (46%) | Past medical history | | Cardiac | 3 (23%) | Vascular | 2 (15%) | Pulmonary | 7 (54%) | Diabetes | 3 (23%) | Insulin | 1 (33%) | NonInsulin | 2 (67%) | Alcohol | 2 (15%) | Tobacco | 9 (69%) | Median packs | 60 (40–300) | Hypertension | 8 (62%) | Prior cholecystectomy | 4 (31%) | Karnofsky performance scale | 90% (70–100) | Extent of liver lesions | | Distinct number | 11 (85%) | Numerous | 2 (15%) | Liver involvement | | <25% | 6 (46%) | 26–50% | 6 (46%) | 51–75% | 1 (8%) | Number liver tumors (median, range) | 4 (1–20) | 1 | 18% | 2 | 9% | ≥3 | 73% | Sum of target lesion(s) size (median, range) | 12.7 cm (2.5–21.8) | Lesion location | | Seg 2–4 | 1 (8%) | Seg 4–8 | 3 (23%) | Seg 5–8 | 2 (15%) | Other | 7 (54%) |
|
|